-transparent.png){kind=logo}
Relationship between serum total bilirubin levels and primary loss of response to Infliximab therapy in Crohn's disease patients. 2025
Jingjing Liu, and
Dingzhe Zhang, and
Yu Wang, and
Yiping Zhang, and
Jianhua Wang, and
Yunhui Li, and
Xiao Chen
Department of Radiology, Funan County People's Hospital, Funan Hospital Affiliated to Fuyang Normal University School of Medicine, Fuyang, China. 1107736532@qq.com.
| UI | MeSH Term | Description | Entries |
|---|
Related Publications
Jingjing Liu, and
Dingzhe Zhang, and
Yu Wang, and
Yiping Zhang, and
Jianhua Wang, and
Yunhui Li, and
Xiao Chen
March 2014,
Inflammatory bowel diseases,
Jingjing Liu, and
Dingzhe Zhang, and
Yu Wang, and
Yiping Zhang, and
Jianhua Wang, and
Yunhui Li, and
Xiao Chen
January 2018,
PloS one,
Jingjing Liu, and
Dingzhe Zhang, and
Yu Wang, and
Yiping Zhang, and
Jianhua Wang, and
Yunhui Li, and
Xiao Chen
April 2014,
Journal of gastroenterology,
Jingjing Liu, and
Dingzhe Zhang, and
Yu Wang, and
Yiping Zhang, and
Jianhua Wang, and
Yunhui Li, and
Xiao Chen
January 2013,
Coronary artery disease,
Jingjing Liu, and
Dingzhe Zhang, and
Yu Wang, and
Yiping Zhang, and
Jianhua Wang, and
Yunhui Li, and
Xiao Chen
June 2014,
Journal of gastroenterology and hepatology,
Jingjing Liu, and
Dingzhe Zhang, and
Yu Wang, and
Yiping Zhang, and
Jianhua Wang, and
Yunhui Li, and
Xiao Chen
October 2013,
Journal of Crohn's & colitis,
Jingjing Liu, and
Dingzhe Zhang, and
Yu Wang, and
Yiping Zhang, and
Jianhua Wang, and
Yunhui Li, and
Xiao Chen
October 2013,
Pharmaceuticals (Basel, Switzerland),
Jingjing Liu, and
Dingzhe Zhang, and
Yu Wang, and
Yiping Zhang, and
Jianhua Wang, and
Yunhui Li, and
Xiao Chen
April 2019,
Clinics (Sao Paulo, Brazil),
Jingjing Liu, and
Dingzhe Zhang, and
Yu Wang, and
Yiping Zhang, and
Jianhua Wang, and
Yunhui Li, and
Xiao Chen
October 2021,
Gastroenterology report,
Jingjing Liu, and
Dingzhe Zhang, and
Yu Wang, and
Yiping Zhang, and
Jianhua Wang, and
Yunhui Li, and
Xiao Chen
January 2020,
Inflammatory bowel diseases,
